Basilea Pharmaceutica AG (BSLN) — Cash Flow Reinvestment Rate
Basilea Pharmaceutica AG (BSLN) has a Cash Flow Reinvestment Rate of 0.06x as of December 2025, reinvesting CHF2.30 Million (capex CHF2.30 Million ) from operating cash flow of CHF39.03 Million. Check Basilea Pharmaceutica AG earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Basilea Pharmaceutica AG Cash Flow Reinvestment Rate (2005–2025)
Historical reinvestment intensity for Basilea Pharmaceutica AG across 8 annual periods. Explore BSLN long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Basilea Pharmaceutica AG (2005–2025)
Year-by-year capital reinvestment analysis for Basilea Pharmaceutica AG. For live market cap and broader valuation context, see Basilea Pharmaceutica AG (BSLN) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | CHF2.62 Million | CHF62.09 Million | CHF2.62 Million | ▲ +15.3% |
| 2024 | 0.04x | CHF2.72 Million | CHF74.36 Million | CHF1.71 Million | ▼ -74.8% |
| 2023 | 0.15x | CHF2.07 Million | CHF14.24 Million | CHF1.03 Million | ▼ -98.9% |
| 2022 | 13.46x | CHF94.95 Million | CHF7.06 Million | CHF3.30 Million | ▲ +321.5% |
| 2017 | 3.19x | CHF60.71 Million | CHF19.01 Million | CHF711.00K | ▲ +35705.9% |
| 2012 | 0.01x | CHF1.32 Million | CHF148.17 Million | CHF1.32 Million | ▼ -23.3% |
| 2010 | 0.01x | CHF1.24 Million | CHF106.64 Million | CHF1.24 Million | ▼ -66.7% |
| 2005 | 0.03x | CHF1.20 Million | CHF34.38 Million | CHF1.20 Million | — |